Fudan University
Clinical trials sponsored by Fudan University, explained in plain language.
-
Could a simple anesthesia change boost pancreatic cancer survival?
Disease control CompletedThis study looked at whether using epidural anesthesia (a numbing shot in the back) during pancreatic cancer surgery helps people live longer and stay cancer-free longer. About 540 adults having surgery for pancreatic cancer took part. The goal was to see if this type of pain con…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 16, 2026 19:47 UTC
-
New drug cocktail shows promise in preventing bile duct cancer return after surgery
Disease control CompletedThis study tested a combination of three drugs (capecitabine, lenvatinib, and tislelizumab) given after surgery to 65 adults with biliary tract cancer. The goal was to see if this treatment could help keep the cancer from coming back. The results focus on how long patients lived …
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New drug combo shows promise for rare immune disorder
Disease control CompletedThis study tested whether combining an interferon-gamma monoclonal antibody with dexamethasone can help adults with a severe immune condition called refractory secondary hemophagocytic lymphohistiocytosis (HLH). The treatment aims to control the overactive immune response. Resear…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Microplastics making you fat? probiotic pill may fight the flab!
Disease control CompletedThis study looked at whether tiny plastic particles (microplastics) we are exposed to daily can contribute to obesity and gut problems. Researchers gave 96 overweight adults a probiotic supplement or a placebo to see if the probiotic could reduce the harmful effects of microplast…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Triple-Drug cocktail shows promise against tough head and neck cancers
Disease control CompletedThis study tested a combination of three drugs—camrelizumab, cetuximab, and chemotherapy—as the first treatment for people with head and neck cancer that had come back or spread. 41 participants received the combination to see how many would have their tumors shrink or disappear.…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Herbal hope: new combo therapy targets advanced pancreatic cancer
Disease control CompletedThis study tested whether adding a Chinese herbal formula (QingyiHuaji) to standard chemotherapy helps people with stage IV pancreatic cancer live longer. About 305 adults with advanced pancreatic cancer were randomly assigned to receive either the herbal formula plus chemo or a …
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Less invasive surgery for rare pancreatic tumor shows promise in large study
Disease control CompletedThis study looked at a rare, low-grade pancreatic tumor called solid pseudopapillary neoplasm (SPN). Researchers wanted to see if a surgery that saves more of the pancreas (parenchyma-sparing resection) is safe and whether removing nearby lymph nodes is necessary. They followed 7…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Heated chemo drug tested for colorectal cancer safety
Disease control CompletedThis early-phase trial tested whether a heated chemotherapy drug called raltitrexed is safe and tolerable for people with colorectal cancer. 30 patients received the treatment directly into their abdomen during surgery. The goal was to find the best dose with the fewest side effe…
Phase: PHASE1 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New pill combo shows promise for small, aggressive breast tumors
Disease control CompletedThis study tested whether taking oral chemotherapy pills (vinorelbine or capecitabine) along with the targeted drug trastuzumab can help prevent breast cancer from coming back in women with small, HER2-positive tumors that have not spread to lymph nodes. A total of 182 women who …
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Promising combo shrinks lung tumors before surgery in early trial
Disease control CompletedThis study tested a drug called serplulimab combined with chemotherapy for people with stage II-IIIA non-small cell lung cancer that could be removed by surgery. The treatment was given before and after surgery to see if it could shrink tumors and improve outcomes. 30 participant…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New combo therapy shows promise for uterine precancer in obese women
Disease control CompletedThis study tested whether adding a diabetes drug (polyethylene glycol loxenatide) to a hormone-releasing IUD (LNG-IUS) could better treat atypical endometrial hyperplasia, a precancerous condition of the uterine lining. The 30 participants were women with obesity who wanted to pr…
Phase: PHASE2, PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 29, 2026 14:18 UTC
-
No more bandage changes? study finds skipping dressings after gut surgery could be just as safe
Symptom relief CompletedThis study tested whether leaving surgical wounds uncovered after gastrointestinal cancer surgery is as safe as changing the dressing every two days. Over 1,100 adults who had elective surgery for gastrointestinal cancer were randomly assigned to either no dressing changes after …
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 15, 2026 19:09 UTC
-
New nerve block shows promise for reducing pain after breast reconstruction
Symptom relief CompletedThis study looked at whether a special nerve block, called an erector spinae plane block, can reduce pain after breast cancer surgery that includes implant reconstruction. One hundred women scheduled for this surgery took part. The goal was to see if the block lowers pain scores …
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 15, 2026 19:01 UTC
-
New combo cuts steroid use while stopping chemo sickness
Symptom relief CompletedThis study tested a way to reduce steroid use while still preventing nausea and vomiting caused by strong chemotherapy. Over 600 adults receiving high-risk chemo were given a combination of netupitant/palonosetron (NEPA) and olanzapine, with less dexamethasone than usual. The goa…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Herbal granule shows promise in easing kidney harm from cancer drugs
Symptom relief CompletedThis study looked at whether Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine—a sign of kidney damage—caused by anti-angiogenesis targeted therapy in 76 adults with advanced liver or bile duct cancer. Participants took the granule for 8 weeks, and r…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 09, 2026 12:07 UTC
-
Can targeted radiation boost lung cancer treatment? 4000-patient study seeks answers.
Knowledge-focused CompletedThis study looked at 4000 people with advanced lung cancer who had a specific gene mutation (EGFR) and were taking a targeted pill. The goal was to find the best time to add focused radiation to shrink any remaining tumors. Researchers tracked when tumors shrank the most and wher…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
Fruit and veggie breakfast sharpens Kids' minds, study finds
Knowledge-focused CompletedThis study looked at whether giving 7-11-year-old children in Shanghai a daily breakfast with at least one fruit and one vegetable could improve their thinking, mood, and attention. Over 250 kids took part, eating this breakfast for 12 weeks. Researchers measured changes in IQ, m…
Phase: NA • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:50 UTC
-
AI predicts stomach cancer comeback: new hope for personalized treatment
Knowledge-focused CompletedThis study used artificial intelligence to predict if stomach cancer will come back after surgery. Researchers analyzed data from 5000 patients to create a model that can identify who is at high risk for early recurrence. This tool can help doctors choose the best follow-up treat…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Ozone's hidden impact on skin revealed in new study
Knowledge-focused CompletedThis study looked at how ozone, a common air pollutant, reacts with natural oils on the skin and what that means for skin health. Forty healthy young adults in Shanghai were exposed to either clean air or ozone. Researchers measured changes in skin chemicals, hydration, moisture …
Phase: NA • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Real-world study examines quality of life and compliance in young breast cancer patients on hormone-blocking therapy
Knowledge-focused CompletedThis study involved 562 premenopausal women in China with hormone receptor-positive breast cancer who received a GnRHa injection to suppress ovarian function after surgery. Researchers measured their quality of life and how well they followed the treatment plan using questionnair…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Colon polyp count linked to future cancer risk, study finds
Knowledge-focused CompletedThis study looked at nearly 3,000 people who had non-advanced colon polyps (small, low-risk growths) found during their first screening colonoscopy. Researchers wanted to see if having more of these polyps increased the chance of developing advanced growths or cancer later. The g…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Real-World data reveals immunotherapy Combo's impact on esophageal cancer
Knowledge-focused CompletedThis study analyzed medical records from 1197 patients in China with advanced esophageal cancer who received immunotherapy (anti-PD-1) plus chemotherapy as their first treatment. The goal was to see how long patients lived and how long the cancer stayed under control in everyday …
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
New model could spot hidden risks in seniors with lung disease and muscle loss
Knowledge-focused CompletedThis study looked at 200 adults over 65 with COPD and a condition called sarcopenic obesity (muscle loss with excess fat). Researchers used a special body composition test (bioelectrical impedance) to see if it could help predict serious outcomes like lung function decline, hospi…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Plant power vs. pollution: can polyphenols shield your health?
Knowledge-focused CompletedThis study looked at whether daily exposure to environmental pollutants harms health and if taking a mix of plant compounds (polyphenols) can help. 98 healthy adults participated in a double-blind trial. Researchers measured changes in gut bacteria, blood markers, and inflammatio…
Phase: NA • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC